Citigroup Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 98,068 shares of ARWR stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,068

Previous 238,016 58.8%

Holding current value

$1.93 Million

Previous $6.19 Million 69.32%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$19.36 - $29.54 $2.71 Million - $4.13 Million	-139,948 Reduced 58.8%	98,068 $1.9 Million
Q2 2024 Aug 12, 2024	SELL	$21.87 - $28.24 $939,710 - $1.21 Million	-42,968 Reduced 15.29%	238,016 $6.19 Million
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $2.56 Million - $3.71 Million	94,042 Added 50.31%	280,984 $8.04 Million
Q4 2023 Feb 09, 2024	BUY	$21.2 - $31.03 $533,052 - $780,218	25,144 Added 15.54%	186,942 $5.72 Million
Q3 2023 Nov 09, 2023	BUY	$26.2 - $36.08 $1.55 Million - $2.14 Million	59,279 Added 57.82%	161,798 $4.35 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $3.28 Million - $5.4 Million	-130,389 Reduced 55.98%	102,519 $3.66 Million
Q1 2023 May 11, 2023	BUY	$23.68 - $38.51 $2.26 Million - $3.68 Million	95,568 Added 69.58%	232,908 $5.92 Million
Q4 2022 Feb 09, 2023	SELL	$28.0 - $40.56 $2.11 Million - $3.06 Million	-75,411 Reduced 35.45%	137,340 $5.57 Million
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $2 Million - $3.27 Million	67,631 Added 46.6%	212,751 $7.03 Million
Q2 2022 Aug 10, 2022	BUY	$27.79 - $50.61 $2.94 Million - $5.36 Million	105,843 Added 269.48%	145,120 $5.11 Million
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $2.41 Million - $4.25 Million	-60,765 Reduced 60.74%	39,277 $1.81 Million
Q4 2021 Feb 10, 2022	BUY	$58.09 - $82.51 $903,531 - $1.28 Million	15,554 Added 18.41%	100,042 $6.63 Million
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $4.93 Million - $7.18 Million	84,488 New	84,488 $5.28 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account